SUGAR-DIP trial: oral medication strategy versus insulin for diabetes in pregnancy, study protocol for a multicentre, open-label, non-inferiority, randomised controlled trial

Autor: Floris Groenendaal, Arie Franx, Rebecca C Painter, Ben Willem Mol, Bas B Van rijn, Leon de Wit, Doortje Rademaker, Daphne N Voormolen, Bettina M C Akerboom, Rosalie M Kiewiet-Kemper, Maarten R Soeters, Marion A L Verwij-Didden, Fahima Assouiki, Daniela H Schippers, Mechteld A R Vermeulen, Simone M I Kuppens, Mirjam M Oosterwerff, Joost J Zwart, Mattheus J M Diekman, Tatjana E Vogelvang, P Rob J Gallas, Sander Galjaard, Willy Visser, Nicole Horree, Tamira K Klooker, Rosemarie Laan, Rik Heijligenberg, Anjoke J M Huisjes, Thomas van Bemmel, Claudia A van Meir, Annewieke W van den Beld, Wietske Hermes, Solrun Vidarsdottir, Anneke G Veldhuis-Vlug, Remke C Dullemond, Henrique J Jansen, Marieke Sueters, Eelco J P de Koning, Judith O E H van Laar, Pleun Wouters-van Poppel, Marina E Sanson-van Praag, Eline S van den Akker, Catherine B Brouwer, Brenda B Hermsen, Bert Jan Potter van Loon, Olivier W H van der Heijden, Bastiaan E de Galan, Marsha van Leeuwen, Johanna A M Wijbenga, Karin de Boer, Arianne C van Bon, Flip W van der Made, Silvia A Eskes, Mirjam Zandstra, William H van Houtum, Babette A M Braams-Lisman, Catharina R G M Daemen-Gubbels, Maurice G A J Wouters, Richard G IJzerman, Nico A Mensing van Charante, Rolf Zwertbroek, Inge M Evers, Harold W de Valk, J Hans deVries

Publikováno v: BMJ Open, Vol 9, Iss 8 (2019)

Introduction In women with gestational diabetes mellitus (GDM) requiring pharmacotherapy, insulin was the established first-line treatment. More recently, oral glucose lowering drugs (OGLDs) have gained popularity as a patient-friendly, less expensiv

Externí odkaz: https://doaj.org/article/fcbb937143a248c0b10a815934bf79df

SUGAR-DIP trial

Autor: Fahima Assouiki, Mirjam M Oosterwerff, P Rob J Gallas, Judith E. Bosmans, Anjoke J.M. Huisjes, Mechteld A R Vermeulen, Olivier W.H. van der Heijden, Remke C. Dullemond, Rosalie M Kiewiet-Kemper, Wietske Hermes, Marion A L Verwij-Didden, William H van Houtum, Sander Galjaard, Floris Groenendaal, Bert Jan Potter van Loon, Mirjam Zandstra, Arianne C van Bon, Marsha van Leeuwen, Maurice G.A.J. Wouters, Joost J Zwart, Catherine B Brouwer, Johanna A M Wijbenga, Babette A M Braams-Lisman, Pleun Wouters-van Poppel, Doortje Rademaker, Silvia A Eskes, Christiana A. Naaktgeboren, Eelco J.P. de Koning, Harold W. de Valk, Catharina R G M Daemen-Gubbels, Tamira K Klooker, Bas B. van Rijn, Eline S van den Akker, Annewieke W van den Beld, Bettina M.C. Akerboom, Thomas van Bemmel, Nicole Horree, J. Hans DeVries, Rosemarie Laan, Solrun Vidarsdottir, Willy Visser, Anneke G Veldhuis-Vlug, Marina E Sanson-van Praag, Leon de Wit, Nico A Mensing van Charante, Daniela H Schippers, Claudia A van Meir, Rebecca C. Painter, Tatjana E Vogelvang, Daphne N. Voormolen, Marieke Sueters, Ben W.J. Mol, Arie Franx, Mattheus J M Diekman, Rolf Zwertbroek, Richard G. IJzerman, Simone M I Kuppens, Bastiaan E. de Galan, Henrique J Jansen, Judith O E H van Laar, Brenda B Hermsen, Flip W van der Made, Rik Heijligenberg, Karin de Boer, Inge M Evers, Maarten R. Soeters

Publikováno v: BMJ Open, 9(8):e029808. BMJ Publishing Group
De Wit, L, Rademaker, D, Voormolen, D N, Akerboom, B M C, Kiewiet-Kemper, R M, Soeters, M R, Verwij-Didden, M A L, Assouiki, F, Schippers, D H, Vermeulen, M A R, Kuppens, S M I, Oosterwerff, M M, Zwart, J J, Diekman, M J M, Vogelvang, T E, Gallas, P R J, Galjaard, S, Visser, W, Horree, N, Klooker, T K, Laan, R, Heijligenberg, R, Huisjes, A J M, Van Bemmel, T, Van Meir, C A, Van Den Beld, A W, Hermes, W, Vidarsdottir, S, Veldhuis-Vlug, A G, Dullemond, R C, Jansen, H J, Sueters, M, De Koning, E J P, Van Laar, J O E H, Wouters-Van Poppel, P, Sanson-Van Praag, M E, Van Den Akker, E S, Brouwer, C B, Hermsen, B B, Potter Van Loon, B J, Van Der Heijden, O W H, De Galan, B E, Van Leeuwen, M, Wijbenga, J A M, De Boer, K, Van Bon, A C, Van Der Made, F W, Eskes, S A, Zandstra, M, Van Houtum, W H, Braams-Lisman, B A M, Daemen-Gubbels, C R G M, Wouters, M G A J, Ijzerman, R G, Mensing Van Charante, N A, Zwertbroek, R, Bosmans, J E, Evers, I M, Mol, B W, De Valk, H W, Groenendaal, F, Naaktgeboren, C A, Painter, R C, Devries, J H, Franx, A & Van Rijn, B B 2019, ' SUGAR-DIP trial : Oral medication strategy versus insulin for diabetes in pregnancy, study protocol for a multicentre, open-label, non-inferiority, randomised controlled trial ', BMJ Open, vol. 9, no. 8, e029808 . https://doi.org/10.1136/bmjopen-2019-029808
BMJ Open, 9, e029808
BMJ Open, Vol 9, Iss 8 (2019)
BMJ open, 9(8):e029808. BMJ Publishing Group
BMJ Open, 9(8). BMJ PUBLISHING GROUP
BMJ Open, 9(8). BMJ Publishing Group
BMJ Open
BMJ Open, 9, 8, pp. e029808

IntroductionIn women with gestational diabetes mellitus (GDM) requiring pharmacotherapy, insulin was the established first-line treatment. More recently, oral glucose lowering drugs (OGLDs) have gained popularity as a patient-friendly, less expensive

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3241fbede6e55b6fb5755b4b2088d6d6
https://doi.org/10.1136/bmjopen-2019-029808

Selenite supplementation in euthyroid subjects with thyroid peroxidase antibodies

Autor: Lutz Schomburg, Silvia A. Eskes, Erwin Birnie, Birgit Hollenbach, Eric Fliers, Erik Endert, Wilmar M. Wiersinga, Josef Köhrle

Publikováno v: Clinical endocrinology, 80(3), 444-451. Wiley-Blackwell
Clinical Endocrinology, 80(3), 444-451. Wiley-Blackwell Publishing Ltd

Euthyroid thyroid peroxidase (TPO-Ab)-positive subjects are at risk for progression to subclinical and overt autoimmune hypothyroidism. Previous studies have shown a decrease in TPO-Ab and improvement of quality-of-life (QoL) in L-T4-treated hypothyr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5d812a5ab33844aafbf673e31e83311
https://doi.org/10.1111/cen.12284

Amiodarone and thyroid

Autor: Silvia A. Eskes, Wilmar M. Wiersinga

Publikováno v: Best practice & research. Clinical endocrinology & metabolism, 23(6), 735-751. Bailliere Tindall Ltd

Assessment of TSH and TPO-Ab before starting amiodarone (AM) treatment is recommended. The usefulness of periodic TSH measurement every 6 months during AM treatment is limited by the often sudden explosive onset of AIT, and the spontaneous return of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a715548d91777457036457c47d64feaa
https://doi.org/10.1016/j.beem.2009.07.001

Prevalenza del deficit dell’ormone della crescita nella tiroidite di Hashimoto

Autor: Silvia A. Eskes, Michele Marinò, E. Endert, E. Fliers, W. M. Wiersinga

Publikováno v: L'Endocrinologo. 11:137-138

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::41f7275249a2d686e503b0f25787fc98
https://doi.org/10.1007/bf03344720